Inflammatory myopathy associated with statins: Report of three cases

Modern Rheumatology

Volumn 24, Issue 2, 2014, Pages 366-371

  Kuncova, Klara ^a   Sedlackova, Marie ^b   Vencovsky, Jiri ^c   Mann, Herman ^c   Tomcik, Michal ^c   Wenchich, Laszlo ^c   Zamecnik, Josef ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Drug induced myopathy; Inflammatory myopathy; Muscle biopsy; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; AUTOANTIBODY; AZATHIOPRINE; CARBON MONOXIDE; CITALOPRAM; CREATINE KINASE; FENOFIBRATE; FUROSEMIDE; LEVOTHYROXINE; METHOTREXATE; METOPROLOL TARTRATE; MITOCHONDRIAL DNA; MYOGLOBIN; PREDNISONE; SIMVASTATIN; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; LUNG CAPACITY; MALAISE; MALE; MIDDLE AGED; MUSCLE BIOPSY; MUSCLE NECROSIS; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYALGIA; PHOTOSENSITIVITY; POLYMYOSITIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SPIROMETRY;

AGED; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS;

EID: 84904807881     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2013.852848     Document Type: Article

References (44)

1. Evans M , Roberts A , Davies S , Rees A.Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Drugs. 2004 ; 64 : 1181-96.
2. Paulweber B.Statins in primary prevention of coronary heart disease. Wien Med Wochenschr. 1999 ; 149 : 129-38.
3. Liao JK , Laufs U.Pleiotropic effects of statins. A nnu Rev Pharmacol Toxicol. 2005 ; 45 : 89-118.
4. Toth PP , Harper CR , Jacobson TA. Clinical characterization and molecular mechanisms of statin myopathy. Expert Rev Cardiovasc Ther. 2008 ; 6 : 955-69.
5. Thompson PD , Clarkson P , Karas RH. Statin-Associated myopathy. JAMA. 2003 ; 289 : 1681-90.
6. McClure D L, Valuck R J, Glanz M , Hokanson J E.Systematic review and meta-Analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present. Pharmacoepidemiol Drug Saf. 2007 ; 16 : 132-43.
7. Folzenlogen D.A case of atorvastatin combined toxic myopathy and inflammatory myositis. JClin Rheumatol. 2001 ; 7 : 340-5.
8. Giordano N , Senesi M , Mattii G , Battisti E , Villanova M , Gennari C.Polymyositis associated with simvastatin. Lancet. 1997 ; 349 : 1600-1.
9. Noel B , Cerottini JP , Panizzon RG. Atorvastatin-induced dermatomyositis. Am J Med. 2001 ; 110 : 670-1.
10. Fauchais AL , Iba Ba J , Maurage P , Kyndt X , Bataille D , Hachulla E , et al. Polymyositis induced or associated with lipid-lowering drugs: five cases. Rev Med Internet. 2004 ; 25 : 294-8.
11. Zuech P , Pauwels C , Duthoit C , Mery L , Somogyi A , Louboutin A, et al. Pravastatin-induced dermatomyositis. Rev Med Internet. 2005 ; 26 : 897-902.
12. Scalvini T , Marocolo D , Cerudelli B , Sleiman I , Balestrieri GP , Giustina G.Pravastatin-Associated myopathy. Report of a case. Recenti Prog Med. 1995 ; 86 : 198-200.
13. Rodriguez-Garcia J L, Serrano Commino M.Lovastatin-Associated dermatomyositis. Postgrad Med J.1996 ; 72 : 694.
14. Thual N , Penven K , Chevallier J M, Dompmartin A , Leroy D.Fluvastatin-induced dermatomyositis. Ann Dermatol Venereol. 2005 ; 132 : 996-9.
15. Takagi A , Shiio Y.Pravastatin-Associated polymyositis, Acase report. Rinsho Shinkeigaku. 2004 ; 44 : 25-7.
16. Khattak F H, Morris I M, Branford W A.Simvastatin-Associated dermatomyositis. Br J Rheumatol. 1994 ; 33 : 199.
17. Christopher-Stine L , Casciola-Rosen L A, Hong G , Chung T , Corse AM , Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthr Rheum. 2010 ; 62 : 2757-66.
18. Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Casciola-Rosen LA. Autoantibodies against 3-hydroxy-3-methylglutarylcoenzyme A reductase (HMGCR) in patients with statin-Associated autoimmune myopathy. Arthr Rheum. 2011;63:713-21.
19. Ghirardello A , Zampieri S , Tarricone E , Iaccarino L , Bendo R , Briani C , et al. Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity. 2006 ; 39 : 217-21.
20. Zamecnik J , Vesely D , Jakubicka B , Simkova L , Pitha J , Schutzner J, et al. Muscle lymphocytic infiltrates in thymoma-Associated myasthenia gravis are phenotypically different from those in polymyositis. Neuromuscul Disord. 2007 ; 17 : 935-42.
21. Vogel H , Zamecnik J.Diagnostic immunohistology of muscle diseases. JNeuropathol Exp Neurol. 2005 ; 64 : 181-93.
22. Bohan A , Peter J B.Polymyositis and dermatomyositis (first of two parts). NEngl J Med. 1975 ; 292 : 344-7.
23. Bohan A , Peter J B.Polymyositis and dermatomyositis (second of two parts). NEngl J Med. 1975 ; 292 : 403-7.
24. Fornuskova D , Brantova O , Tesarova M , Stiburek L , Honzik T , Wenchich L , et al. The impact of mitochondrial tRNA mutations on the amount of ATP synthase differs in the brain compared to other tissues. Biochim Biophys Acta. 2008 ; 1782 : 317-25.
25. Dalakas MC. Toxic and drug-induced myopathies. JNeurol Neurosurg Psychiatry. 2009 ; 80 : 832-8.
26. Pascuzzi R M.Drugs and toxins associated with myopathies. Curr Opin Rheumatol. 1998 ; 10 : 511-20.
27. Sieb J P, Gillessen T.Iatrogenic and toxic myopathies. Muscle Nerve. 2003 ; 27 : 142-56.
28. Radcliffe K A, Campbell W W.Statin myopathy. Curr Neurol Neurosci Rep. 2008 ; 8 : 66-72.
29. A hmad A , Fletcher M T, Roy T M.Simvastatin-induced lupus-like syndrome. Tenn Med. 2000 ; 93 : 21-2.
30. Liebhaber MI , Wright RS , Gelberg HJ , Dyer Z , Kupperman JL. Polymyalgia, hypersensitivity pneumonitis and other reactions in patients receiving HMG-CoA reductase inhibitors: a report of ten cases. Chest. 1999 ; 115 : 886-9.
31. Rudski L, Rabinovitch MA, Danoff D.Systemic immune reactions to HMG-CoA reductase inhibitors. Report of 4 cases and review of the literature. Medicine (Baltimore). 1998;77:378-83.
32. Needham M , Fabian V , Knezevic W , Panegyres P , Zilko P , Mastaglia FL. Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscul Disord. 2007 ; 17 : 194-200.
33. Mach F.Statins as immunomodulatory agents. Circulation. 2004;109:II15-17.
34. Kwak B R, Mulhaupt F , Mach F.A therosclerosis: anti-inflammatory and immunomodulatory activities of statins. Autoimmun Rev. 2003 ; 2 : 332-8.
35. Mulhaupt F , Myit S , Mach F.Statins as a newly recognized type of immunomodulator. Nat Med. 2000 ; 6 : 1399-402.
36. Sadeghi M M, Tiglio A , Sadigh K , O'D onnell L , Collinge M , Pardi R , et al. Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. Transplantation. 2001 ; 71 : 1262-8.
37. Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA. Immune-mediated necrotizing myopathy associated with statins. Muscle Nerve. 2010;41:185-90.
38. Nagaraju K , Casciola-Rosen L , Lundberg I , Rawat R , Cutting S , Thapliyal R, et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthr Rheum. 2005 ; 52 : 1824-35.
39. Henriques-Pons A , Nagaraju K.Nonimmune mechanisms of muscle damage in myositis: role of the endoplasmic reticulum stress response and autophagy in the disease pathogenesis. Curr Opin Rheumatol. 2009 ; 21 : 581-7.
40. Wallace DC. Mitochondrial DNA mutations in disease and aging. Environ Mol Mutagen. 2010;51:440-50.
41. Caso G , Kelly P , McNurlan MA , Lawson WE. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. Am J Cardiol. 2007 ; 99 : 1409-12.
42. Young J M, Florkowski C M, Molyneux S L, McEwan R G, Frampton CM , George PM , et al. Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol. 2007 ; 100 : 1400-3.
43. Phillips P S, Haas R H, Bannykh S , Hathaway S , Gray N L, Kimura B J, et al. Statin-Associated myopathy with normal creatine kinase levels. Ann Intern Med. 2002 ; 137 : 581-5.
44. Lamperti C , Naini A B, Lucchini V , Prelle A , Bresolin N , Moggio M , et al. Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol. 2005 ; 62 : 1709-12.